Frontline primary tumor resection followed by systemic therapy in metastatic breast cancer patients may be non- inferior to systemic treatment alone: A retrospective study.
(2020). Frontline primary tumor resection followed by systemic therapy in metastatic breast cancer patients may be non- inferior to systemic treatment alone: A retrospective study.. EKB Journal Management System, 8(3), 43-48. doi: 10.21608/secioj.2020.119759
. "Frontline primary tumor resection followed by systemic therapy in metastatic breast cancer patients may be non- inferior to systemic treatment alone: A retrospective study.". EKB Journal Management System, 8, 3, 2020, 43-48. doi: 10.21608/secioj.2020.119759
(2020). 'Frontline primary tumor resection followed by systemic therapy in metastatic breast cancer patients may be non- inferior to systemic treatment alone: A retrospective study.', EKB Journal Management System, 8(3), pp. 43-48. doi: 10.21608/secioj.2020.119759
Frontline primary tumor resection followed by systemic therapy in metastatic breast cancer patients may be non- inferior to systemic treatment alone: A retrospective study.. EKB Journal Management System, 2020; 8(3): 43-48. doi: 10.21608/secioj.2020.119759

Frontline primary tumor resection followed by systemic therapy in metastatic breast cancer patients may be non- inferior to systemic treatment alone: A retrospective study.

SECI Oncology Journal
Article 4, Volume 8, Issue 3, September 2020, Page 43-48  XML
DOI: 10.21608/secioj.2020.119759
View on SCiNiTO View on SCiNiTO
Abstract
Primary tumor resection in metastatic breast cancer (MBC) remains a palliative procedure. Its impact as an upfront option on survival is debatable. No data from our locality addressed this issue
Keywords
Breast cancer; Surgery; Systemic treatment
Supplementary Files
Statistics
Article View: 131